Jeff Jones

Stock Analyst at Oppenheimer

(0.84)
# 2422
Out of 5,441 analysts
113
Total ratings
Success rate
Average return
27 Stocks
Name Action PT Current % Upside Ratings Updated
CRBP Corbus Pharmaceutica...
Maintains: Outperform
56 53
8.67 511.3% 10 Aug 6, 2025
KYMR Kymera Therapeutics
Maintains: Outperform
56 53
37.69 40.62% 5 Jun 27, 2025
AVBP ArriVent BioPharma
Maintains: Outperform
39 44
17.4 152.87% 3 Jun 24, 2025
YMAB Y-mAbs Therapeutics
Maintains: Outperform
20 15
8.52 76.06% 3 May 29, 2025
CMMB Chemomab Therapeutic...
Maintains: Outperform
11 10
0.95 952.63% 8 May 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
26 25
4.34 476.04% 2 May 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
19 17
1.41 1105.67% 4 May 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
15 17
4.37 289.02% 5 May 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
85 86
31.9 169.59% 2 May 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
28 18
9.22 95.23% 4 Jan 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 5 Dec 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
22 16
3.72 330.11% 7 Nov 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
10 9
2.67 237.08% 10 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
48 45
1.69 2562.72% 6 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 4 Jun 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Perform
n/a
n/a n/a 3 Apr 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
32 30
31.33 -4.25% 3 Feb 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
13 15
21.55 -30.39% 3 Jan 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 3 Jun 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
28800
9.02 319190.47% 3 May 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 2 May 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
13
12.5 4% 2 May 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
15
1.4 971.43% 5 May 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
75
0.62 11996.77% 2 Mar 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
125 150
199.92 -24.97% 6 Mar 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
1600 1100
2.79 39326.52% 2 Nov 17, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Outperform
193
n/a n/a 1 Jul 18, 2022